Literature DB >> 12163384

Insulin-like growth factor-binding protein 3 expression increases during immortalization of cervical keratinocytes by human papillomavirus type 16 E6 and E7 proteins.

Allison J Berger1, Astrid Baege, Tracy Guillemette, James Deeds, Ron Meyer, Gary Disbrow, Richard Schlegel, Robert Schlegel.   

Abstract

Human papillomaviruses (HPVs) infect cervical epithelial cells and induce both benign and precancerous lesions. High-risk HPVs promote the development of cervical cancer in vivo and can immortalize cervical epithelial cells in vitro, whereas low-risk HPVs cannot. We used cDNA microarrays and quantitative polymerase chain reaction to compare cellular gene expression in primary cervical epithelial cells during a time course after retroviral transduction with either low-risk or high-risk E6/E7 genes. At early passages, cervical cells transduced with high-risk E6/E7 genes demonstrated increased expression of the cell cycle-regulated genes CDC2 and ubiquitin carrier E2-C. At later passages, these same cells exhibited dramatic increases in insulin-like growth factor-binding protein-3 (IGFBP-3) mRNA and both secreted an intracellular protein, with mRNA levels increasing approximately 85-fold. Corroborating these in vitro studies, in situ hybridization of cervical biopsies with an IGFBP-3 riboprobe revealed high levels of expression in high-grade squamous intraepithelial neoplasia but not in normal cervical epithelium. Our in vitro results indicate that overexpression of IGFBP-3 is a late event after E6/E7 expression, and analysis of cervical lesions indicates that overexpression of this gene is also seen in vivo.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12163384      PMCID: PMC1850738          DOI: 10.1016/S0002-9440(10)64215-0

Source DB:  PubMed          Journal:  Am J Pathol        ISSN: 0002-9440            Impact factor:   4.307


  31 in total

1.  Generation of papillomavirus-immortalized cell lines from normal human ectocervical, endocervical, and vaginal epithelium that maintain expression of tissue-specific differentiation proteins.

Authors:  R N Fichorova; J G Rheinwald; D J Anderson
Journal:  Biol Reprod       Date:  1997-10       Impact factor: 4.285

Review 2.  Genetic changes associated with immortalization. A review.

Authors:  E L Duncan; R R Reddel
Journal:  Biochemistry (Mosc)       Date:  1997-11       Impact factor: 2.487

3.  The human papillomavirus type 16 E6 and E7 oncoproteins dissociate cellular telomerase activity from the maintenance of telomere length.

Authors:  H Stöppler; D P Hartmann; L Sherman; R Schlegel
Journal:  J Biol Chem       Date:  1997-05-16       Impact factor: 5.157

Review 4.  Human papillomaviruses and associated malignancies.

Authors:  R M Alani; K Münger
Journal:  J Clin Oncol       Date:  1998-01       Impact factor: 44.544

5.  Insulin-like growth factor (IGF)-binding protein-3 induces apoptosis and mediates the effects of transforming growth factor-beta1 on programmed cell death through a p53- and IGF-independent mechanism.

Authors:  R Rajah; B Valentinis; P Cohen
Journal:  J Biol Chem       Date:  1997-05-02       Impact factor: 5.157

6.  Elevated expression and activity of mitotic regulatory proteins in human papillomavirus-immortalized keratinocytes.

Authors:  K E Steinmann; X F Pei; H Stöppler; R Schlegel; R Schlegel
Journal:  Oncogene       Date:  1994-02       Impact factor: 9.867

7.  Insulin-like growth factor-binding protein enhancement of insulin-like growth factor-I (IGF-I)-mediated DNA synthesis and IGF-I binding in a human breast carcinoma cell line.

Authors:  J C Chen; Z M Shao; M S Sheikh; A Hussain; D LeRoith; C T Roberts; J A Fontana
Journal:  J Cell Physiol       Date:  1994-01       Impact factor: 6.384

8.  Telomerase activation by the E6 gene product of human papillomavirus type 16.

Authors:  A J Klingelhutz; S A Foster; J K McDougall
Journal:  Nature       Date:  1996-03-07       Impact factor: 49.962

9.  Regulation of insulin-like growth factor 1 binding protein 3 levels by epidermal growth factor and retinoic acid in cervical epithelial cells.

Authors:  S Andreatta-Van Leyen; J R Hembree; R L Eckert
Journal:  J Cell Physiol       Date:  1994-08       Impact factor: 6.384

10.  Induction of the growth inhibitor IGF-binding protein 3 by p53.

Authors:  L Buckbinder; R Talbott; S Velasco-Miguel; I Takenaka; B Faha; B R Seizinger; N Kley
Journal:  Nature       Date:  1995-10-19       Impact factor: 49.962

View more
  6 in total

1.  Plasma levels of insulin-like growth factor-1 and insulin-like growth factor binding protein-3 in women with cervical neoplasia.

Authors:  Si Won Lee; Soo Yoon Lee; Sa Ra Lee; Woong Ju; Seung Cheol Kim
Journal:  J Gynecol Oncol       Date:  2010-09-28       Impact factor: 4.401

2.  IGFBP-3, a marker of cellular senescence, is overexpressed in human papillomavirus-immortalized cervical cells and enhances IGF-1-induced mitogenesis.

Authors:  Astrid C Baege; Gary L Disbrow; Richard Schlegel
Journal:  J Virol       Date:  2004-06       Impact factor: 5.103

3.  Epidermal growth factor receptor regulates aberrant expression of insulin-like growth factor-binding protein 3.

Authors:  Munenori Takaoka; Hideki Harada; Claudia D Andl; Kenji Oyama; Yoshio Naomoto; Kelly L Dempsey; Andres J Klein-Szanto; Wafik S El-Deiry; Adda Grimberg; Hiroshi Nakagawa
Journal:  Cancer Res       Date:  2004-11-01       Impact factor: 12.701

4.  Myc and human papillomavirus type 16 E7 genes cooperate to immortalize human keratinocytes.

Authors:  Xuefeng Liu; Gary L Disbrow; Hang Yuan; Vjekoslav Tomaic; Richard Schlegel
Journal:  J Virol       Date:  2007-09-05       Impact factor: 5.103

5.  The Karyopherin proteins, Crm1 and Karyopherin beta1, are overexpressed in cervical cancer and are critical for cancer cell survival and proliferation.

Authors:  Pauline J van der Watt; Christopher P Maske; Denver T Hendricks; M Iqbal Parker; Lynette Denny; Dhirendra Govender; Michael J Birrer; Virna D Leaner
Journal:  Int J Cancer       Date:  2009-04-15       Impact factor: 7.396

Review 6.  IGF axis and other factors in HPV-related and HPV-unrelated carcinogenesis (review).

Authors:  Julia Durzyńska
Journal:  Oncol Rep       Date:  2014-09-19       Impact factor: 3.906

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.